38 results
8-K
EX-99.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
about Trudhesa with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at www.Trudhesa.com or 1-800-555-DRUG. You
8-K
IMPLQ
Impel Pharmaceuticals Inc
2 Nov 23
Departure of Directors or Certain Officers
5:20pm
2011 to January 2014 he served as senior director of sales at Warner Chilcott Pharmaceuticals where he led the women’s healthcare, osteoporosis … and urology sales forces. Mr. Paolillo began his healthcare career at EURO RSCG LIFE LM&P, a full-service healthcare advertising agency, before joining Warner
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
process or sales and marketing terms;
changes in the structure of healthcare payment systems;
actual or anticipated changes in earnings estimates … not to promote any products for off-label uses, but healthcare providers may use our products off-label as the FDA does not restrict or regulate
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
of any Hazardous Materials, and any investigation, monitoring, corrective action or response action with respect to any of the foregoing.
“Healthcare … , labeling, promotion and provision of and payment for drugs, medical or healthcare products, items and services, including, without limitation, 45 C.F.R
8-K
EX-10.1
ev5 ez1futz
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
EX-99.1
g1bfqtarg35t6yu
12 May 23
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
8:03am
PRE 14A
gi2 21682ie5t
14 Apr 23
Preliminary proxy
4:11pm
8-K
EX-99.1
m08ws4ewh7geii
14 Nov 22
Impel PHARMACEUTICALS Announces THIRD Quarter 2022 Financial Results and Provides CORPORATE Update
7:55am
8-K
EX-99.1
8qmjn67af39tfknf229
15 Aug 22
Impel PHARMACEUTICALS Announces SECOND Quarter 2022 Financial Results and Provides CORPORATE Update
8:06am
CORRESP
ilfjx190qx 42s7hb3
20 May 22
Correspondence with SEC
12:00am
8-K
EX-99.1
yeffkmv9k
16 May 22
Impel PHARMACEUTICALS Announces first Quarter 2022 Financial Results and Provides CORPORATE Update
8:23am